FDA ESG Integration: Why Now Is the Time to Move Beyond Manual Submissions

Traditional submission workflows require teams to assemble, format, validate, coordinate, and then manually upload documents through the gateway. That manual step may seem manageable in isolation, but it adds up quickly.

A formatting issue or validation error can send teams back to the beginning, creating delays, rework, added cost, and frustration. When submission volumes increase, those inefficiencies scale with them. What may feel like a familiar process can become a real obstacle to speed and predictability.

The ESG integration enables direct, automated, and secure communication between internal regulatory systems and the FDA. Instead of relying on fragmented handoffs and manual uploads, teams can trigger submissions directly from their publishing or review environment.

This approach supports a broad range of submission types across portfolios, including NDAs, BLAs, ANDAs, INDs, DMFs, and medical device applications. It also strengthens consistency by reducing the number of manual touchpoints in the process.

Speed matters, but it is only part of the story. Earlier validation helps catch issues before they turn into costly rework. Automation removes repetitive manual tasks so teams can focus on higher-value work instead of spending time on mechanical steps.

As submission volume grows, organizations can scale more effectively without increasing headcount at the same pace. At the same time, integrated dashboards, notifications, and audit trails improve visibility, governance, transparency, and compliance.

In the webinar demo, I showed how an integrated workflow can connect to the Unified Submission Portal, use the required credentials, trigger an ESG submission, automatically create the required compressed package, and track status updates and acknowledgments in one place.

That means less time spent zipping files, uploading packages, and chasing status emails – and more confidence that the right output is being submitted. It also creates a smoother experience from submission initiation through tracking.

I would say the time to integrate is now because the move toward automated submissions is already underway. Waiting to integrate increases operational and compliance risk, while early adopters can gain faster timelines, better efficiency, and greater agility as requirements continue to evolve.

The question is no longer whether automation belongs in regulatory submissions. The more practical question is whether your current process is prepared for it.